Ceppellini Lecture 2012: Collateral damage from HLA mismatching in kidney transplantation

Tissue Antigens

Volumn 82, Issue 4, 2013, Pages 235-242

  Opelz, G ^a   Dohler B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Collaborative Transplant Study; Death with functioning graft; Hip fracture; Human leukocyte antigen; Kidney transplantation; Lymphoma; Matching; Mismatch; Survival

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; STEROID;

CARDIOVASCULAR DISEASE; DONOR; GRAFT RECIPIENT; GRAFT SURVIVAL; HIP FRACTURE; HLA MATCHING; HLA MISMATCHING; HLA SYSTEM; HLA TYPING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

COLLABORATIVE TRANSPLANT STUDY; DEATH WITH FUNCTIONING GRAFT; HIP FRACTURE; HUMAN LEUKOCYTE ANTIGEN; KIDNEY TRANSPLANTATION; LYMPHOMA; MATCHING; MISMATCH; SURVIVAL;

ADOLESCENT; CARDIOVASCULAR DISEASES; GRAFT SURVIVAL; HIP FRACTURES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOMA, NON-HODGKIN; STEROIDS; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 84890850355     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12147     Document Type: Review

References (45)

1. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999: 354: 1147-52.
2. Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007: 84: 137-43.
3. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009: 88: 23-9.
4. Opelz G, Döhler B, Ruhenstroth Aet al. The collaborative transplant study registry. Transplant Rev (Orlando) 2013: 27: 43-5.
5. Opelz G, Mytilineos J, Scherer S et al. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study. Lancet 1991: 338: 461-3.
6. Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004: 4: 222-30.
7. Opelz G, Döhler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 2010: 90: 292-7.
8. Opelz G, Döhler B. Impact of HLA mismatching on incidence of posttransplant non-Hodgkin lymphoma after kidney transplantation. Transplantation 2010: 89: 567-72.
9. Opelz G, Döhler B. Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation 2011: 91: 65-9.
10. Opelz G, Döhler B. Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report. Am J Transplant 2012: 12: 3031-8.
11. Qiu J, Cai J, Terasaki PL. Death with a functioning graft in kidney transplant recipients. Clin Transpl 2004: 379-86.
12. Meier-Kriesche HU, Arndorfer JA, Kaplan B. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002: 13: 769-72.
13. Chang SH, Russ GR, Chadban SJ, Campbell SB, McDonald SP. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007: 84: 611-8.
14. Tapiawala SN, Tinckam KJ, Cardella CJ et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010: 21: 153-61.
15. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011: 57 (A8): e1-526.
16. Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation 2005: 80: 193-7.
17. Dror Y, Greenberg M, Taylor G et al. Lymphoproliferative disorders after organ transplantation in children. Transplantation 1999: 67: 990-8.
18. Faye A, Vilmer E. Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options. Paediatr Drugs 2005: 7: 55-65.
19. Opelz G, Daniel V, Naujokat C, Döhler B. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 2009: 88: 962-7.
20. Swinnen LJ, Costanzo-Nordin MR, Fisher SG et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990: 323: 1723-8.
21. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993: 342: 1514-6.
22. Bakker NA, van Imhoff GW, Verschuuren EA et al. HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical. Transplantation 2005: 80: 595-9.
23. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998: 147-58.
24. Baan CC, Weimar W. Intragraft cytokine gene expression: implications for clinical transplantation. Transpl Int 1998: 11: 169-80.
25. Tosato G, Teruya-Feldstein J, Setsuda J, Pike SE, Jones KD, Jaffe ES. Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD. Springer Semin Immunopathol 1998: 20: 405-23.
26. Abbott KC, Oglesby RJ, Hypolite IO et al. Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 2001: 11: 450-7.
27. Patel S, Kwan JT, McCloskey E et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 2001: 16: 1863-70.
28. Maalouf NM, Shane E. Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab 2005: 90: 2456-65.
29. Brandenburg VM, Westenfeld R, Ketteler M. The fate of bone after renal transplantation. J Nephrol 2004: 17: 190-204.
30. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003: 14: 617-30.
31. Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. J Am Soc Nephrol 2007: 18: 223-34.
32. Malluche HH, Monier-Faugere MC, Herberth J. Bone disease after renal transplantation. Nat Rev Nephrol 2010: 6: 32-40.
33. Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B. Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 1999: 67: 1218-22.
34. Ramsey-Goldman R, Dunn JE, Dunlop DD et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 1999: 14: 456-63.
35. Durieux S, Mercadal L, Orcel P et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002: 74: 496-500.
36. O'Shaughnessy EA, Dahl DC, Smith CL, Kasiske BL. Risk factors for fractures in kidney transplantation. Transplantation 2002: 74: 362-6.
37. Nikkel LE, Hollenbeak CS, Fox EJ, Uemura T, Ghahramani N. Risk of fractures after renal transplantation in the United States. Transplantation 2009: 87: 1846-51.
38. Ball AM, Gillen DL, Sherrard D et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002: 288: 3014-8.
39. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M. Epidemiology of hip fractures. Bone 1996: 18: 57S-63.
40. Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT. Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 2004: 15: 160-7.
41. Sijpkens YW, Doxiadis I, Mallat MJ et al. Early versus late acute rejection episodes in renal transplantation. Transplantation 2003: 75: 204-8.
42. Woodle ES, Susskind B, Alloway RR et al. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens. Transplant Proc 2005: 37: 809-11.
43. Moore J, Tan K, Cockwell P et al. Risk factors for acute rejection in renal transplant recipients experiencing delayed graft function. Clin Transplant 2008: 22: 634-8.
44. Kraus ES, Parekh RS, Oberai P et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009: 9: 1826-34.
45. Ensrud KE, Ewing SK, Taylor BC et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007: 62: 744-51.